Telehealth Reviews · Comparison

Ro vs Noom Med vs Found: The Branded-Pathway GLP-1 Telehealth Head-to-Head for Women (2026)

By the US Health Digest editorial team · Published August 14, 2026

Ro, Noom Med, and Found all prescribe FDA-approved branded GLP-1s by telehealth, and none includes the medication in its program fee — so the real comparison is fee versus service. As of August 2026: Ro charges $39 for the first month, then $149/month (less prepaid) and posts cash medication prices; Noom's branded tier is $129/month after month one, billed quarterly (re-verified 2026-08-26; it was $99 when this page was first published on 2026-08-14), routing prescriptions to NovoCare or LillyDirect; Found runs $129–$199 per 30 days self-pay or $49/month via insurance. Prices change often — confirm on the provider's own pricing page before you pay.

This head-to-head is for one decision: you want a program that prescribes only FDA-approved branded medication — Wegovy, Zepbound, Ozempic (off-label), or the newer oral options. If you are still upstream of that choice, start with our broader 2026 comparison of GLP-1 telehealth programs for women and our explainer on how GLP-1 telehealth works. US Health Digest has no affiliate or commercial relationship with Ro, Noom, or Found; every fact below was checked against the companies' own pages.

What you pay the program

Ro (Ro Body) charges $39 for the first month, refunded if a clinician finds you ineligible for GLP-1s, then $149/month rolling — or $99, $89, or $74 per month on prepaid 3-, 6-, and 12-month plans. The membership covers provider check-ins, on-demand messaging, side-effect and dose management, and insurance support; Ro states plainly that "the cost of medication is not included in the Ro Body membership fee."

Noom Med sells its branded pathway as "Telehealth for Branded Meds": $129/month after month one, billed quarterly, with the page stating that on this tier "the cost of medication is not included" — the Noom behavior-change app is bundled in; the medication is not. (Noom also sells compounded "GLP-1Rx" tiers with medication included — a different product category; see our compounded vs branded explainer. Noom's own pages disagree on their price: $249/month on the pricing page, $279/month in its cost guide.)

Found is the least tidy on price. Its published offer terms list a CORE plan at $129 per 30 days and a PLUS plan at $199 per 30 days self-pay — or $49/month through insurance — while its homepage advertises plans "from $99/month" for compounded options. The terms state that "GLP-1 medications and Contrave® are not included in any subscription plan fee." When homepage and offer terms show different numbers, get the price you are actually offered in writing at checkout.

What you pay for the medication

This is where the three genuinely differ. Both manufacturers now sell direct to self-pay patients well below retail list prices — the landscape we map in our 2026 guide to GLP-1 costs without insurance.

Ro publishes cash prices on its own pricing page — as of August 2026, Wegovy pill and Foundayo pill from $149/month, Wegovy pen from $199/month, Zepbound KwikPen from $299/month — which Ro describes as matching NovoCare® and LillyDirect® pricing and has run Wegovy cash fulfillment through an integration with Novo Nordisk's NovoCare® Pharmacy since 2025. Per Ro's insurance page, only the Wegovy pen, Zepbound pen, and Ozempic can be run through insurance via Ro; the oral options are cash-pay.

Noom Med does not dispense branded medication itself. Its support pages state that payment and shipping are managed by the manufacturer's pharmacy: Wegovy (pen and pill) routes to NovoCare®, while Zepbound (vials and KwikPen) and Foundayo route to LillyDirect®, where Noom's own cost guide puts Zepbound self-pay at $299–$449/month, and has announced its LillyDirect integration publicly. You pay the pharmacy directly, on top of the program fee.

Found offers branded Wegovy and Zepbound with insurance navigation or direct-pay routing; its cost guides describe Lilly's single-dose Zepbound vials at $349–$699/month through LillyDirect, while its homepage quotes branded pens "from $650/mo+" without coverage — the homepage figure is for pens without insurance, the lower range is for Lilly's single-dose vials bought direct, and the two pages do not reconcile. Found publishes no consolidated branded price list in its offer terms; medication prices appear only in marketing and blog pages.

Clinical oversight

All three use licensed clinicians rather than a named personal physician, and none guarantees yours will be a doctor. Ro says "every doctor or nurse practitioner you interact with is licensed to prescribe medicine and treat patients in your state." Noom describes evaluation by "a board-certified physician or a physician-supervised nurse practitioner." Found says "a board-certified clinician evaluates your assessment" and that its providers are "specifically trained in obesity care"; per its terms, medical services are delivered by independent contracted medical groups, not by Found itself. What any of them should deliver — a real yes/no prescribing decision, a published dose-escalation plan, side-effect management — is covered in our guide to what happens in a GLP-1 medical review. The stakes are real: in STEP 1, semaglutide 2.4 mg averaged 14.9% body-weight reduction at 68 weeks versus 2.4% with placebo (treatment-policy estimand; about 74% of participants were women) (NEJM 2021). In SURMOUNT-1 — a separate trial, not a head-to-head with STEP 1 — tirzepatide's 15 mg dose averaged 20.9% at 72 weeks (treatment-regimen estimand) (NEJM 2022), and the SURMOUNT-5 head-to-head found greater weight loss with tirzepatide than semaglutide (NEJM 2025) — drug choice, not program choice, is the larger clinical variable.

Insurance help

Ro assigns an insurance concierge that verifies benefits, files prior authorizations ("1–2 weeks" typical), and moves you to cash options if coverage fails. Noom's Care Coordinators submit prior authorizations (up to 14 days) and appeals (up to 90 days) and help apply manufacturer savings cards, but cannot guarantee coverage. Found alone has a substantial pre-signup tool: its free GLP-1 Coverage Checker contacts your insurer and reports coverage, estimated cost, and whether prior authorization is required before you commit. For plan-by-plan coverage, see our 2026 GLP-1 insurance coverage guide.

Cancellation

Ro's pricing page does not state cancellation terms; they live in the Terms of Use: cancel online or by email at least 48 hours before renewal, fees are non-refundable once paid, and the $39 start fee is refunded only if you are never prescribed. Noom lets you cancel in-app or via its subscription portal, with the subscription running to the end of the paid cycle — the branded tier bills quarterly after month one, so a mid-cycle cancellation still uses up the quarter. Found allows cancellation anytime by email or the in-app "Cancel Membership" link, effective within 24 hours, with fees otherwise "final and non-refundable"; per its offer terms, leaving a discounted multi-month plan early triggers re-billing at the non-discounted $129 per 30 days. Stopping medication is a clinical event, not just a billing one: in SURMOUNT-4, participants withdrawn from tirzepatide regained a substantial share of lost weight within a year (JAMA 2024).

The head-to-head at a glance (August 2026)

Trade-offs, honestly stated

Ro has the most transparent medication pricing and the deepest pharmacy integration, but the highest rolling fee at $149/month — concierge service you may not need if your insurance already covers a pen. Noom Med's branded tier bundles the behavior-change app, but its ongoing fee rose from $99 to $129/month between 2026-08-14 and 2026-08-26 — a 30% increase in twelve days, and the clearest possible argument for checking a provider's own pricing page on the day you sign up rather than trusting any comparison, including this one; the other trade-offs are quarterly billing and a site that leads with its compounded tiers, so you must select the branded pathway deliberately. (Its pricing page's "lose 37% more weight with Noom habits" is a company marketing claim, not an independent trial result.) Found has the strongest pre-purchase insurance tooling and the cheapest insurance-based plan at $49/month, but its self-pay pricing is scattered across pages that do not agree, and its multi-month discounts carry a clawback if you leave early.

Questions to ask before you sign up

• What is my total first-90-day cost — program fee plus medication — in writing, at checkout?
• Is the medication FDA-approved branded product only, and which pharmacy dispenses it?
• If insurance denies prior authorization, what happens next, and what is the cash price for my drug and dose?
• Who is my prescriber, in which state are they licensed, and how do I reach them between refills?
• What is the dose-escalation schedule, and what happens to billing if I need to slow it down for side effects?
• How do I cancel, how many hours or days of notice do I need, and what do I owe if I leave a multi-month plan early?
• Am I planning pregnancy in the next year? GLP-1s are not used in pregnancy — raise it at intake (what a legitimate intake should ask).

Sources